Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Henriette U. Balinda"'
Autor:
Henriette U. Balinda, William J. Kelly, Virginia G. Kaklamani, Kate I. Lathrop, Marcela Mazo Canola, Pegah Ghamasaee, Gangadhara R. Sareddy, Joel Michalek, Andrea R. Gilbert, Prathibha Surapaneni, Stefano Tiziani, Renu Pandey, Jennifer Chiou, Alessia Lodi, John R. Floyd, Andrew J. Brenner
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Sacituzumab Govitecan (SG) is an antibody-drug conjugate that has demonstrated efficacy in patients with TROP-2 expressing epithelial cancers. In a xenograft model of intracranial breast cancer, SG inhibited tumor growth and increased mouse
Externí odkaz:
https://doaj.org/article/6d91bfe0b91b4bbd854a96e2dea7ba0a
Autor:
Bryan Mcclellan, Linda A. deGraffenried, Aleksandra Gruslova, Gangadhara R. Sareddy, Victoria Alers, Andrew Brenner, Ratna K. Vadlamudi, Michael E. Garcia, Suryavathi Viswanadhapalli, Tim Huang, Henriette U. Balinda
Publikováno v:
Breast Cancer Research and Treatment. 187:375-386
The majority of breast cancers are estrogen receptor (ERα) positive making endocrine therapy a mainstay for these patients. Unfortunately, resistance to endocrine therapy is a common occurrence. Fatty acid synthase (FASN) is a key enzyme in lipid bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69697bbbdc0fb50e263b1212a2e5d318
https://doi.org/10.1007/s10549-021-06231-6
https://doi.org/10.1007/s10549-021-06231-6
Publikováno v:
Exp Cell Res
Invasive melanoma is an aggressive form of skin cancer with high incidence of mortality. The process of invasion is a crucial primary step in the metastatic cascade, yet the mechanisms involved are still under investigation. Here we document a critic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b649892b948f5186a145a9abb48ca2
https://europepmc.org/articles/PMC9086996/
https://europepmc.org/articles/PMC9086996/
Autor:
Aleksandra, Gruslova, Bryan, McClellan, Henriette U, Balinda, Suryavathi, Viswanadhapalli, Victoria, Alers, Gangadhara R, Sareddy, Tim, Huang, Michael, Garcia, Linda, deGraffenried, Ratna K, Vadlamudi, Andrew J, Brenner
Publikováno v:
Breast cancer research and treatment. 187(2)
The majority of breast cancers are estrogen receptor (ERα) positive making endocrine therapy a mainstay for these patients. Unfortunately, resistance to endocrine therapy is a common occurrence. Fatty acid synthase (FASN) is a key enzyme in lipid bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c10127d1f8e5e9ebe2d3a5a8048b7b6
https://pubmed.ncbi.nlm.nih.gov/33893909
https://pubmed.ncbi.nlm.nih.gov/33893909
Autor:
Henriette U Balinda
Publikováno v:
Cancer Research. 82:P5-05
INTRODUCTION: The majority of breast cancers are estrogen receptor (ERα) positive making endocrine therapy a mainstay for these patients. Unfortunately, resistance to endocrine therapy is a common occurrence. Fatty acid synthase (FASN) is a key enzy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc27b3f93ff8358e3e53b8bc821a04af
https://doi.org/10.1158/1538-7445.sabcs21-p5-05-10
https://doi.org/10.1158/1538-7445.sabcs21-p5-05-10